Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Host cell surface receptors for adenoviral entry are a diverse group of membrane proteins and glycans that facilitate the attachment and internalization of adenoviruses (AdV) into host cells (Wikipedia, 2024; PMC, 2020). The entry process typically involves a two-step mechanism: initial high-affinity attachment of the viral fiber knob to a primary receptor, followed by a secondary interaction between the viral penton base and co-receptors that trigger endocytosis (Cell, 1993; PMC, 2022). Key primary receptors include the coxsackievirus and adenovirus receptor (CAR) for many serotypes, CD46 (membrane cofactor protein) for species B and D, and desmoglein-2 (DSG2) for certain species B viruses (PubMed, 2020; mBio, 2025). Internalization is primarily mediated by alpha-v integrins (such as alpha-v-beta-3 and alpha-v-beta-5), which recognize the RGD motif on the viral capsid and stimulate clathrin-mediated endocytosis (PMC, 2024; PubMed, 1993). These receptors are critical targets in both antiviral drug development, where inhibitors like suramin or decoy receptors aim to block viral entry, and in gene therapy or oncolytic virotherapy, where vectors are engineered to target or avoid specific receptors to optimize tissue tropism and safety (MDPI, 2019; PMC, 2024).
Inhibition of viral attachment to primary receptors (CAR, CD46, DSG2) and blocking of co-receptor-mediated internalization (integrins) to prevent viral entry and subsequent replication.
9 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Host cell surface receptors for adenoviral entry.